Quadrant Capital Group LLC Sage Therapeutics, Inc. Transaction History

Quadrant Capital Group LLC

$1.42 Billion
Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 1,120 shares of SAGE stock, worth $6,417. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,120

Previous 336 233.33%

Holding current value

$6,417

Previous $3,000 166.67%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$7.02 - $13.08 $5,503 - $10,254	784 Added 233.33%	1,120 $8,000
Q2 2024 Aug 12, 2024	BUY	$10.58 - $17.9 $3,554 - $6,014	336 New	336 $3,000
Q3 2023 Nov 14, 2023	BUY	$16.75 - $48.98 $10,837 - $31,690	647 Added 1540.48%	689 $14,000
Q2 2023 Aug 09, 2023	SELL	$40.65 - $59.54 $813 - $1,190	-20 Reduced 32.26%	42 $1,000
Q1 2023 May 11, 2023	BUY	$37.27 - $46.57 $745 - $931	20 Added 47.62%	62 $2,000
Q4 2022 Feb 10, 2023	SELL	$32.2 - $43.61 $805 - $1,090	-25 Reduced 37.31%	42 $1,000
Q2 2022 Aug 09, 2022	BUY	$27.52 - $37.99 $1,155 - $1,595	42 Added 168.0%	67 $2,000
Q1 2022 May 06, 2022	SELL	$30.71 - $45.71 $1,044 - $1,554	-34 Reduced 57.63%	25 $1,000
Q4 2021 Feb 01, 2022	BUY	$37.06 - $47.11 $1,148 - $1,460	31 Added 110.71%	59 $3,000
Q3 2021 Nov 12, 2021	SELL	$40.26 - $57.37 $1,288 - $1,835	-32 Reduced 53.33%	28 $1,000
Q2 2021 Aug 09, 2021	SELL	$54.88 - $79.29 $493 - $713	-9 Reduced 13.04%	60 $3,000
Q1 2021 May 12, 2021	SELL	$70.65 - $96.76 $847 - $1,161	-12 Reduced 14.81%	69 $5,000
Q4 2020 Feb 16, 2021	BUY	$58.41 - $89.06 $876 - $1,335	15 Added 22.73%	81 $7,000
Q3 2020 Nov 13, 2020	BUY	$41.13 - $62.45 $1,686 - $2,560	41 Added 164.0%	66 $4,000
Q2 2020 Aug 13, 2020	SELL	$25.95 - $43.15 $2,205 - $3,667	-85 Reduced 77.27%	25 $1,000
Q1 2020 May 15, 2020	BUY	$26.15 - $77.24 $2,693 - $7,955	103 Added 1471.43%	110 $3,000
Q4 2019 Feb 03, 2020	SELL	$60.18 - $154.77 $10,170 - $26,156	-169 Reduced 96.02%	7 $0
Q3 2019 Oct 24, 2019	SELL	$140.29 - $189.96 $24,129 - $32,673	-172 Reduced 49.43%	176 $23,000
Q1 2019 Apr 29, 2019	BUY	$89.33 - $163.65 $30,461 - $55,804	341 Added 4871.43%	348 $53,000
Q4 2018 Jan 17, 2019	BUY	$81.94 - $139.71 $573 - $977	7 New	7 $0

Others Institutions Holding SAGE

# of Institutions

218

Shares Held

46.4M

Call Options Held

847K

Put Options Held

188K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $340M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC Sage Therapeutics, Inc. Transaction History